Advertisement






Click here for more guidelines.
CME Topic Collections Past Issues Search Current Issue Home
     

J Am Coll Cardiol, 2009; 53:399, doi:10.1016/j.jacc.2008.10.020
© 2009 by the American College of Cardiology Foundation
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Song, Z.-Z.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Song, Z.-Z.
Related Collections
Right arrowRelated Article

CORRESPONDENCE: LETTER TO THE EDITOR

Left Ventricular Mass and the Outcome of Patients With Hypertrophic Cardiomyopathy

Ze-Zhou Song, MS*

* Department of Ultrasound, The First Affiliated Hospital, College of Medicine, Zhejiang University, 79 Qingchun Road, Hangzhou, Zhejiang Province 310003, Peoples Republic of China (Email: zezhou_song{at}126.com).


I read with great interest the study by Olivotto et al. (1), which concluded that the left ventricular (LV) mass by cardiovascular magnetic resonance proved more sensitive than a maximal LV thickness ≥30 mm in predicting outcome of patients with hypertrophic cardiomyopathy. However, as stated in an Editorial Comment by Reichek (2), the number of cardiac deaths in the study was small. In other words, LV mass by cardiovascular magnetic resonance did not prove more sensitive in predicting outcome in the presently enrolled patients. What happened when the authors chose other end points such as progression to severe functional limitation (New York Heart Association functional class III or IV) and/or sustained, life-threatening ventricular arrhythmias requiring the implantation of a cardioverter-defibrillator that are used for the entire cohort of patients with hypertrophic cardiomyopathy as previously described (3)? If the aforementioned end points were chosen, did LV mass prove more sensitive than a maximal LV thickness ≥30 mm in predicting the outcome of patients with hypertrophic cardiomyopathy? In addition, what were the causes of death in the study by Olivotto et al. (1)?


    Footnotes
 
Please note: The author would like to thank the Editors of JACC for the opportunity to ask these questions about such an important article.


    References
 Top
 References
 
1. Olivotto I, Maron MS, Autore C, et al. Assessment and significance of left ventricular mass by cardiovascular magnetic resonance in hypertrophic cardiomyopathy J Am Coll Cardiol 2008;52:559-566.[Abstract/Free Full Text]

2. Reichek N. Hypertrophic cardiomyopathy: cardiac magnetic resonance imaging changes the paradigm J Am Coll Cardiol 2008;52:567-568.[Free Full Text]

3. Olivotto I, Gistri R, Petrone P, Pedemonte E, Vargiu D, Cecchi F. Maximum left ventricular thickness and risk of sudden death in patients with hypertrophic cardiomyopathy J Am Coll Cardiol 2003;41:315-321.[Abstract/Free Full Text]


Related Article

Reply
Iacopo Olivotto, Martin S. Maron, Franco Cecchi, and Barry J. Maron
J. Am. Coll. Cardiol. 2009 53: 399. [Full Text] [PDF]




This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Song, Z.-Z.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Song, Z.-Z.
Related Collections
Right arrowRelated Article

 
  CME Topic Collections Past Issues Search Current Issue Home

Advertisement